You are subscribed to the Drug Topics Hospital Pharmacists' Report.

Drug Topics Hospital Pharmacists' Report

Print Subscribe

Digital Edition Subscribe

February 14, 2013

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TOP STORY

Fungal meningitis outbreak treatments spark debate

Opposition has arisen in how patients who were exposed to the fungal meningitis outbreak last year should have been treated. Which side do you take? » More

Continuing Education

New CPE Series: February activity available now

Welcome to the sixth activity in our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The February activity covers psychosocial considerations in the management of diabetes.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

ADVERTISEMENT

Pharmacist e-Link: Get the Edge
Pharmacist e-Link is the premier source for online news, information, and continuing education for pharmacists. Registration is FREE. Join Now and be automatically entered to win a $100 Amazon gift card!

TODAY'S HEADLINES

Calcium intake may increase CVD risk in men

Calcium from diet sources and supplements may increase the risk of cardiovascular disease in men, but not women, study finds.
» More

FDA issues proposal for early-stage Alzheimer's drugs

A draft proposal recently issued by FDA is designed to guide companies that are developing new treatments for patients who are in the early stages of Alzheimer's disease. See what they're proposing and if you agree with the recommendations. » More

NACDS, others press for holistic opioid management

During an FDA hearing on the use and possible restriction of opioids for the treatment of chronic pain, the National Association of Chain Drug Stores and other industry stakeholders pressed their cases for opioid management in the wake of the prescription drug abuse epidemic. There's still time to submit a comment on the issue. » More

TAKE OUR SURVEY

New guidelines for managing type 2 diabetes in children and adolescents were released by the American Academy of Pediatrics.

How knowledgeable are you in managing this disease state in this population?

- Very knowledgeable
- Somewhat knowledgeable
- Little to no knowledge

Click Here to let us know.

 

Check these out too

Internet, apps drive healthcare decisions

FDA approves new multiple myeloma drug

FDA grants priority review to cancer drug

Med school policies linked to Rx behavior

Voices

Anticoagulation Update

JP at Large: Loaded doesn't kill you

View from the Zoo: Goal of improved health falls short

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News and analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group